|Bid||31.20 x 0|
|Ask||31.21 x 0|
|Day's range||30.80 - 31.83|
|52-week range||18.34 - 71.60|
|Beta (5Y monthly)||2.17|
|PE ratio (TTM)||N/A|
|Earnings date||01 Jun 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||39.07|
MindMed’s Nasdaq debut Tuesday made it the second psychedelic drug developer to be listed on a major U.S. stock exchange.
Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, CBD and vaporization device company, today announced Southern Glazer's Wine & Spirits ("Southern Glazer's"), the world's pre-eminent distributor of beverage alcohol, as the distribution partner for its U.S. portfolio of CBD-infused beverages. This partnership announcement follows the recent launch of Quatreau – Canopy's first line of CBD-infused beverages sold in the U.S market.
Vivien Azer, Cowen Managing Director and Senior Research Analyst joins the Yahoo Finance Live panel to discuss the wave of state level legalizations and the future of the cannabis industry.